Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticancer Drug Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Targeted Drugs
1.2.3 Cytotoxic Drugs
1.2.4 Hormonal Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Anticancer Drug Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Immunotherapy
1.3.3 Targeted Therapy
1.3.4 Chemotherapy
1.3.5 Hormonal Therapy
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anticancer Drug Market Perspective (2018-2034)
2.2 Anticancer Drug Growth Trends by Region
2.2.1 Global Anticancer Drug Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Anticancer Drug Historic Market Size by Region (2018-2023)
2.2.3 Anticancer Drug Forecasted Market Size by Region (2024-2034)
2.3 Anticancer Drug Market Dynamics
2.3.1 Anticancer Drug Industry Trends
2.3.2 Anticancer Drug Market Drivers
2.3.3 Anticancer Drug Market Challenges
2.3.4 Anticancer Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticancer Drug Players by Revenue
3.1.1 Global Top Anticancer Drug Players by Revenue (2018-2023)
3.1.2 Global Anticancer Drug Revenue Market Share by Players (2018-2023)
3.2 Global Anticancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticancer Drug Revenue
3.4 Global Anticancer Drug Market Concentration Ratio
3.4.1 Global Anticancer Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticancer Drug Revenue in 2024
3.5 Anticancer Drug Key Players Head office and Area Served
3.6 Key Players Anticancer Drug Product Solution and Service
3.7 Date of Enter into Anticancer Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticancer Drug Breakdown Data by Type
4.1 Global Anticancer Drug Historic Market Size by Type (2018-2023)
4.2 Global Anticancer Drug Forecasted Market Size by Type (2024-2034)
5 Anticancer Drug Breakdown Data by Application
5.1 Global Anticancer Drug Historic Market Size by Application (2018-2023)
5.2 Global Anticancer Drug Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Anticancer Drug Market Size (2018-2034)
6.2 North America Anticancer Drug Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Anticancer Drug Market Size by Country (2018-2023)
6.4 North America Anticancer Drug Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anticancer Drug Market Size (2018-2034)
7.2 Europe Anticancer Drug Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Anticancer Drug Market Size by Country (2018-2023)
7.4 Europe Anticancer Drug Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anticancer Drug Market Size (2018-2034)
8.2 Asia-Pacific Anticancer Drug Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Anticancer Drug Market Size by Region (2018-2023)
8.4 Asia-Pacific Anticancer Drug Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anticancer Drug Market Size (2018-2034)
9.2 Latin America Anticancer Drug Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Anticancer Drug Market Size by Country (2018-2023)
9.4 Latin America Anticancer Drug Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticancer Drug Market Size (2018-2034)
10.2 Middle East & Africa Anticancer Drug Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Anticancer Drug Market Size by Country (2018-2023)
10.4 Middle East & Africa Anticancer Drug Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Anticancer Drug Introduction
11.1.4 Roche Revenue in Anticancer Drug Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Celgene
11.2.1 Celgene Company Detail
11.2.2 Celgene Business Overview
11.2.3 Celgene Anticancer Drug Introduction
11.2.4 Celgene Revenue in Anticancer Drug Business (2018-2023)
11.2.5 Celgene Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Anticancer Drug Introduction
11.3.4 Pfizer Revenue in Anticancer Drug Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Anticancer Drug Introduction
11.4.4 Bristol-Myers Squibb Revenue in Anticancer Drug Business (2018-2023)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Anticancer Drug Introduction
11.5.4 Novartis Revenue in Anticancer Drug Business (2018-2023)
11.5.5 Novartis Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Anticancer Drug Introduction
11.6.4 AstraZeneca Revenue in Anticancer Drug Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Detail
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Anticancer Drug Introduction
11.7.4 Teva Pharmaceuticals Revenue in Anticancer Drug Business (2018-2023)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Anticancer Drug Introduction
11.8.4 Bayer Revenue in Anticancer Drug Business (2018-2023)
11.8.5 Bayer Recent Development
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Detail
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Anticancer Drug Introduction
11.9.4 GlaxoSmithKline Revenue in Anticancer Drug Business (2018-2023)
11.9.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Anticancer Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Targeted Drugs
Table 3. Key Players of Cytotoxic Drugs
Table 4. Key Players of Hormonal Drugs
Table 5. Key Players of Others
Table 6. Global Anticancer Drug Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Anticancer Drug Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Anticancer Drug Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Anticancer Drug Market Share by Region (2018-2023)
Table 10. Global Anticancer Drug Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Anticancer Drug Market Share by Region (2024-2034)
Table 12. Anticancer Drug Market Trends
Table 13. Anticancer Drug Market Drivers
Table 14. Anticancer Drug Market Challenges
Table 15. Anticancer Drug Market Restraints
Table 16. Global Anticancer Drug Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Anticancer Drug Market Share by Players (2018-2023)
Table 18. Global Top Anticancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drug as of 2024)
Table 19. Ranking of Global Top Anticancer Drug Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Anticancer Drug Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Anticancer Drug Product Solution and Service
Table 23. Date of Enter into Anticancer Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Anticancer Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Anticancer Drug Revenue Market Share by Type (2018-2023)
Table 27. Global Anticancer Drug Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Anticancer Drug Revenue Market Share by Type (2024-2034)
Table 29. Global Anticancer Drug Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Anticancer Drug Revenue Market Share by Application (2018-2023)
Table 31. Global Anticancer Drug Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Anticancer Drug Revenue Market Share by Application (2024-2034)
Table 33. North America Anticancer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Anticancer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Anticancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Anticancer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Anticancer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Anticancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Anticancer Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Anticancer Drug Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Anticancer Drug Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Anticancer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Anticancer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Anticancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Anticancer Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Anticancer Drug Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Anticancer Drug Market Size by Country (2024-2034) & (US$ Million)
Table 48. Roche Company Detail
Table 49. Roche Business Overview
Table 50. Roche Anticancer Drug Product
Table 51. Roche Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Celgene Company Detail
Table 54. Celgene Business Overview
Table 55. Celgene Anticancer Drug Product
Table 56. Celgene Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 57. Celgene Recent Development
Table 58. Pfizer Company Detail
Table 59. Pfizer Business Overview
Table 60. Pfizer Anticancer Drug Product
Table 61. Pfizer Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Bristol-Myers Squibb Company Detail
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Anticancer Drug Product
Table 66. Bristol-Myers Squibb Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Novartis Company Detail
Table 69. Novartis Business Overview
Table 70. Novartis Anticancer Drug Product
Table 71. Novartis Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. AstraZeneca Company Detail
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Anticancer Drug Product
Table 76. AstraZeneca Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Teva Pharmaceuticals Company Detail
Table 79. Teva Pharmaceuticals Business Overview
Table 80. Teva Pharmaceuticals Anticancer Drug Product
Table 81. Teva Pharmaceuticals Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 82. Teva Pharmaceuticals Recent Development
Table 83. Bayer Company Detail
Table 84. Bayer Business Overview
Table 85. Bayer Anticancer Drug Product
Table 86. Bayer Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. GlaxoSmithKline Company Detail
Table 89. GlaxoSmithKline Business Overview
Table 90. GlaxoSmithKline Anticancer Drug Product
Table 91. GlaxoSmithKline Revenue in Anticancer Drug Business (2018-2023) & (US$ Million)
Table 92. GlaxoSmithKline Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anticancer Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Anticancer Drug Market Share by Type: 2024 VS 2034
Figure 3. Targeted Drugs Features
Figure 4. Cytotoxic Drugs Features
Figure 5. Hormonal Drugs Features
Figure 6. Others Features
Figure 7. Global Anticancer Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Anticancer Drug Market Share by Application: 2024 VS 2034
Figure 9. Immunotherapy Case Studies
Figure 10. Targeted Therapy Case Studies
Figure 11. Chemotherapy Case Studies
Figure 12. Hormonal Therapy Case Studies
Figure 13. Others Case Studies
Figure 14. Anticancer Drug Report Years Considered
Figure 15. Global Anticancer Drug Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 16. Global Anticancer Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 17. Global Anticancer Drug Market Share by Region: 2024 VS 2034
Figure 18. Global Anticancer Drug Market Share by Players in 2024
Figure 19. Global Top Anticancer Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticancer Drug as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Anticancer Drug Revenue in 2024
Figure 21. North America Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. North America Anticancer Drug Market Share by Country (2018-2034)
Figure 23. United States Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Europe Anticancer Drug Market Share by Country (2018-2034)
Figure 27. Germany Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. France Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. U.K. Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Italy Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Russia Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Nordic Countries Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Asia-Pacific Anticancer Drug Market Share by Region (2018-2034)
Figure 35. China Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Japan Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. South Korea Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Southeast Asia Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. India Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Australia Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Latin America Anticancer Drug Market Share by Country (2018-2034)
Figure 43. Mexico Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Brazil Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Middle East & Africa Anticancer Drug Market Share by Country (2018-2034)
Figure 47. Turkey Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Saudi Arabia Anticancer Drug Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Roche Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 50. Celgene Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 51. Pfizer Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 53. Novartis Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 54. AstraZeneca Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 55. Teva Pharmaceuticals Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 56. Bayer Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Anticancer Drug Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed